Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Breast Neoplasms 2 Stomatitis 1 Stomach Neoplasms 1 Sarcoma 1 Prostate Cancer Metastatic 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oral Ulcer 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Glioblastoma 1 Carcinoma, Squamous Cell 1 Brain Neoplasms 1

Interventions

enzalutamide 5 Prednisone 5 cabazitaxel 4 Docetaxel 3 Abiraterone Acetate 3 fludrocortisone acetate 1 Zuclomiphene 1 XRP6258 1 Standard of Care 1 Prednisolone 1 Midazolam 1 LY3023414 1 Injections 1 Hydrocortisone 1 Dexamethasone 1 Abituzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Prostate Cancer Metastatic × Hydrocortisone × Clear all

NCT06136624 2026-05-05

OMAHA-003

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡